Ocular Therapeutix Ownership 2024 | Who Owns Ocular Therapeutix Now?
Institutional Ownership
102.89%
Insider Ownership
0.92%
Retail Ownership
-3.80%
Institutional Holders
142.00
Ocular Therapeutix Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUMMER ROAD LLC | 11.28% | 98.54% | 14,885,633 | 525,000 | 3.66% | 101,817,730 | Jun 30, 2024 |
| VR ADVISER, LLC | 9.67% | 5.56% | 12,762,462 | - | - | 87,295,240 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 9.64% | 2.60% | 12,721,460 | - | - | 87,014,786 | Jun 30, 2024 |
| BLACKROCK INC. | 8.73% | 0.00% | 11,520,326 | 3,456,623 | 42.87% | 78,799,029 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.52% | 0.00% | 8,612,101 | 1,376,970 | 19.03% | 58,906,770 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 6.11% | 0.73% | 8,060,000 | 911,064 | 12.74% | 55,130,400 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 4.03% | 3.79% | 5,319,148 | - | - | 36,382,972 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 4.02% | 8.29% | 5,307,500 | -1,345,638 | -20.23% | 36,303,300 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 3.90% | 2.86% | 5,150,000 | -661,436 | -11.38% | 35,226,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.97% | 0.00% | 3,920,663 | 1,518,283 | 63.20% | 26,817,335,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.80% | 0.05% | 3,695,047 | 3,320,047 | 885.35% | 25,274,121 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.61% | 0.00% | 3,452,087 | 966,044 | 38.86% | 23,617,170 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.52% | 0.54% | 3,324,468 | - | - | 22,739,361 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 2.10% | 15.96% | 2,771,130 | 135,843 | 5.15% | 18,954,529 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.05% | 0.05% | 2,706,663 | 2,706,663 | 100.00% | 18,513,575 | Jun 30, 2024 |
| DELTEC ASSET MANAGEMENT LLC | 1.96% | 3.39% | 2,590,265 | 226,181 | 9.57% | 17,717,413 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.84% | 2.61% | 2,425,000 | - | - | 16,587,000 | Jun 30, 2024 |
| BRAIDWELL LP | 1.25% | 0.35% | 1,643,770 | 1,643,770 | 100.00% | 11,243,387 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.89% | 0.00% | 1,170,163 | -998,150 | -46.03% | 8,003,914 | Jun 30, 2024 |
| MORGAN STANLEY | 0.88% | 0.00% | 1,162,481 | -210,554 | -15.33% | 7,951,371 | Jun 30, 2024 |
Ocular Therapeutix's largest institutional shareholder is SUMMER ROAD LLC, holding 11.28% of the company's total share outstanding, currently valued at $101.82M. The top 10 institutional shareholders own together 66.85% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUMMER ROAD LLC | 11.28% | 98.54% | 14,885,633 | 525,000 | 3.66% | 101,817,730 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 2.10% | 15.96% | 2,771,130 | 135,843 | 5.15% | 18,954,529 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 4.02% | 8.29% | 5,307,500 | -1,345,638 | -20.23% | 36,303,300 | Jun 30, 2024 |
| VR ADVISER, LLC | 9.67% | 5.56% | 12,762,462 | - | - | 87,295,240 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.57% | 3.95% | 750,000 | 750,000 | 100.00% | 5,130,000 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 4.03% | 3.79% | 5,319,148 | - | - | 36,382,972 | Jun 30, 2024 |
| DELTEC ASSET MANAGEMENT LLC | 1.96% | 3.39% | 2,590,265 | 226,181 | 9.57% | 17,717,413 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 3.90% | 2.86% | 5,150,000 | -661,436 | -11.38% | 35,226,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.84% | 2.61% | 2,425,000 | - | - | 16,587,000 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 9.64% | 2.60% | 12,721,460 | - | - | 87,014,786 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.15% | 0.92% | 200,400 | - | - | 1,370,736 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.39% | 0.89% | 514,642 | 514,642 | 100.00% | 3,520,151 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 6.11% | 0.73% | 8,060,000 | 911,064 | 12.74% | 55,130,400 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.38% | 0.66% | 500,000 | -224,685 | -31.00% | 3,420,000 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.34% | 0.57% | 442,509 | 66,309 | 17.63% | 3,026,762 | Jun 30, 2024 |
| SECOND LINE CAPITAL, LLC | 0.20% | 0.55% | 262,810 | 262,810 | 100.00% | 1,797,620 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.52% | 0.54% | 3,324,468 | - | - | 22,739,361 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.76% | 0.40% | 1,000,000 | 1,000,000 | 100.00% | 6,840,000 | Jun 30, 2024 |
| BRAIDWELL LP | 1.25% | 0.35% | 1,643,770 | 1,643,770 | 100.00% | 11,243,387 | Jun 30, 2024 |
| NOTTINGHAM ADVISORS, INC. | 0.15% | 0.16% | 193,266 | - | - | 1,321,939 | Jun 30, 2024 |
The largest Ocular Therapeutix shareholder by % of total assets is SUMMER ROAD LLC. The company owns 14.89M shares of Ocular Therapeutix (OCUL), representing 98.54% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 8.73% | 0.00% | 11,520,326 | 3,456,623 | 42.87% | 78,799,029 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.80% | 0.05% | 3,695,047 | 3,320,047 | 885.35% | 25,274,121 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.05% | 0.05% | 2,706,663 | 2,706,663 | 100.00% | 18,513,575 | Jun 30, 2024 |
| BRAIDWELL LP | 1.25% | 0.35% | 1,643,770 | 1,643,770 | 100.00% | 11,243,387 | Jun 30, 2024 |
| STATE STREET CORP | 2.97% | 0.00% | 3,920,663 | 1,518,283 | 63.20% | 26,817,335,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.52% | 0.00% | 8,612,101 | 1,376,970 | 19.03% | 58,906,770 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.76% | 0.40% | 1,000,000 | 1,000,000 | 100.00% | 6,840,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.61% | 0.00% | 3,452,087 | 966,044 | 38.86% | 23,617,170 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 6.11% | 0.73% | 8,060,000 | 911,064 | 12.74% | 55,130,400 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.78% | 0.00% | 1,036,171 | 809,118 | 356.36% | 7,087,409 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.57% | 3.95% | 750,000 | 750,000 | 100.00% | 5,130,000 | Jun 30, 2024 |
| SUMMER ROAD LLC | 11.28% | 98.54% | 14,885,633 | 525,000 | 3.66% | 101,817,730 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.41% | 0.01% | 536,119 | 516,706 | 2661.65% | 3,667,054 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.39% | 0.89% | 514,642 | 514,642 | 100.00% | 3,520,151 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.84% | 0.00% | 1,110,454 | 447,782 | 67.57% | 7,597,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.33% | 0.00% | 429,592 | 429,592 | 100.00% | 2,938,408 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.51% | 0.00% | 679,417 | 410,236 | 152.40% | 4,647,212 | Jun 30, 2024 |
| UBS GROUP AG | 0.57% | 0.00% | 748,733 | 265,227 | 54.85% | 5,121,334 | Jun 30, 2024 |
| APTUS CAPITAL ADVISORS, LLC | 0.20% | 0.03% | 262,810 | 262,810 | 100.00% | 1,797,620 | Jun 30, 2024 |
| SECOND LINE CAPITAL, LLC | 0.20% | 0.55% | 262,810 | 262,810 | 100.00% | 1,797,620 | Jun 30, 2024 |
As of Jun 30 2024, Ocular Therapeutix's largest institutional buyer is BLACKROCK INC.. The company purchased 3.46M stocks of OCUL, valued at $78.80M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | - | - | - | -1,728,723 | -100.00% | - | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 4.02% | 8.29% | 5,307,500 | -1,345,638 | -20.23% | 36,303,300 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.89% | 0.00% | 1,170,163 | -998,150 | -46.03% | 8,003,914 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.32% | 0.00% | 416,773 | -796,672 | -65.65% | 2,850,727 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | 0.00% | 45,900 | -726,466 | -94.06% | 313,956 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 3.90% | 2.86% | 5,150,000 | -661,436 | -11.38% | 35,226,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.52% | 0.02% | 689,017 | -397,777 | -36.60% | 4,712,876 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -383,026 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -336,132 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.03% | 0.00% | 40,725 | -332,578 | -89.09% | 278,559,000 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.38% | 0.66% | 500,000 | -224,685 | -31.00% | 3,420,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.88% | 0.00% | 1,162,481 | -210,554 | -15.33% | 7,951,371 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -193,600 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -169,331 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -160,142 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.04% | 0.00% | 55,314 | -129,994 | -70.15% | 378,348 | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | - | - | - | -115,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -82,058 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -74,531 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 6,034 | -63,058 | -91.27% | 41,274 | Jun 30, 2024 |
As of Jun 30 2024, Ocular Therapeutix's biggest institutional seller is GREAT POINT PARTNERS LLC. The company sold -1.73M shares of OCUL, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 2.05% | 0.05% | 2,706,663 | 2,706,663 | 100.00% | 18,513,575 | Jun 30, 2024 |
| BRAIDWELL LP | 1.25% | 0.35% | 1,643,770 | 1,643,770 | 100.00% | 11,243,387 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.76% | 0.40% | 1,000,000 | 1,000,000 | 100.00% | 6,840,000 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.57% | 3.95% | 750,000 | 750,000 | 100.00% | 5,130,000 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.39% | 0.89% | 514,642 | 514,642 | 100.00% | 3,520,151 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.33% | 0.00% | 429,592 | 429,592 | 100.00% | 2,938,408 | Jun 30, 2024 |
| APTUS CAPITAL ADVISORS, LLC | 0.20% | 0.03% | 262,810 | 262,810 | 100.00% | 1,797,620 | Jun 30, 2024 |
| SECOND LINE CAPITAL, LLC | 0.20% | 0.55% | 262,810 | 262,810 | 100.00% | 1,797,620 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.15% | 0.00% | 197,900 | 197,900 | 100.00% | 1,353,636,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.14% | 0.00% | 186,060 | 186,060 | 100.00% | 1,272,650 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 83,715 | 83,715 | 100.00% | 572,611 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 0.15% | 61,859 | 61,859 | 100.00% | 423,116 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 58,572 | 58,572 | 100.00% | 400,632 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 53,500 | 53,500 | 100.00% | 365,673 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.03% | 0.00% | 44,500 | 44,500 | 100.00% | 304,380 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.05% | 41,165 | 41,165 | 100.00% | 281,569 | Jun 30, 2024 |
| GRANT/GROSSMENDELSOHN, LLC | 0.03% | 0.11% | 36,039 | 36,039 | 100.00% | 246,507 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.03% | 0.00% | 35,720 | 35,720 | 100.00% | 244,325 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.02% | 0.04% | 32,900 | 32,900 | 100.00% | 225,036 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 28,151 | 28,151 | 100.00% | 192,553 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.02% | 0.00% | 22,900 | 22,900 | 100.00% | 156,636 | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.00% | 22,088 | 22,088 | 100.00% | 151,000 | Jun 30, 2024 |
| DUDLEY & SHANLEY, INC. | 0.01% | 0.02% | 16,200 | 16,200 | 100.00% | 110,808 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.01% | 0.00% | 14,481 | 14,481 | 100.00% | 99,050 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.01% | 0.04% | 12,667 | 12,667 | 100.00% | 86,643 | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 0.01% | 0.00% | 11,976 | 11,976 | 100.00% | 82,000 | Jun 30, 2024 |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 0.01% | 0.04% | 11,200 | 11,200 | 100.00% | 76,608 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.00% | 10,114 | 10,114 | 100.00% | 69,000 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.01% | 0.02% | 10,087 | 10,087 | 100.00% | 68,995 | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 2,355 | 2,355 | 100.00% | 16,108 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 1,325 | 1,325 | 100.00% | 9,063 | Jun 30, 2024 |
| TFC FINANCIAL MANAGEMENT, INC. | 0.00% | 0.00% | 300 | 300 | 100.00% | 2,052 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 274 | 274 | 100.00% | 1,875 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 234 | 234 | 100.00% | 1,601 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | - | 68 | 68 | 100.00% | 465 | Jun 30, 2024 |
Ocular Therapeutix's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 2.71M shares, valued at $18.51M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | - | - | - | -1,728,723 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -383,026 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -336,132 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -193,600 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -169,331 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -160,142 | -100.00% | - | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | - | - | - | -115,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -82,058 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -74,531 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -62,054 | -100.00% | - | Jun 30, 2024 |
| LINCOLN NATIONAL CORP | - | - | - | -57,226 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -56,981 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -44,300 | -100.00% | - | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | - | - | - | -39,122 | -100.00% | - | Jun 30, 2024 |
| BALBOA WEALTH PARTNERS | - | - | - | -38,000 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -31,852 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -29,700 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -28,946 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -28,741 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -26,976 | -100.00% | - | Jun 30, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | - | - | - | -23,039 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -21,543 | -100.00% | - | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | - | -21,200 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -20,523 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -15,312 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -12,537 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -11,755 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -10,899 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -10,304 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,106 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -2,600 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -2,536 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -220 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -76 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Ocular Therapeutix's largest sold out institutional shareholder by shares sold is GREAT POINT PARTNERS LLC, sold -1.73M shares, valued at -, as of undefined.
Ocular Therapeutix Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 4.07% | 14,515 | - | - | Feb 29, 2024 |
| PARADIGM FUNDS | 0.54% | 140,000 | -20,000 | -12.50% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.12% | 1,047,500 | 1,047,500 | - | Jan 31, 2024 |
| BUFFALO FUNDS | 0.10% | 678,385 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 45,271 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.07% | 70,477 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.05% | 1,003 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 202,645 | 57,434 | 39.55% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 16,776 | 4,375 | 35.28% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.02% | 48,879 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 6,212,336 | 548,284 | 9.68% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 33,311 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 117,516 | - | - | Mar 28, 2024 |
| FORUM FUNDS | 0.01% | 27,640 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,013,100 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 39,757 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.01% | 317,230 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,221 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.01% | 74,388 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.01% | 20,820 | 2,031 | 10.81% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,545 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 39,930 | 39,930 | - | Aug 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.01% | 221,202 | 6,787 | 3.17% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.01% | 29,063 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 11,531 | 3,257 | 39.36% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 51,824 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 789,252 | 69,611 | 9.67% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 88,325 | 36,072 | 69.03% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 28,752 | 309 | 1.09% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 22,310 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 39,474 | -456 | -1.14% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 172,335 | -101,017 | -36.95% | Jan 31, 2024 |
| AMG FUNDS III | 0.00% | 9,795 | - | - | Mar 28, 2024 |
| SSGA FUNDS | 0.00% | 758 | - | - | Feb 29, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 79,746 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 5,747 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,360 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 36,956 | 4,706 | 14.59% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,265 | 1,490 | 39.47% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 10,105 | 10,105 | - | Mar 28, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 12,337 | -383 | -3.01% | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 15,684 | - | - | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 234,725 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 499 | - | - | Apr 30, 2021 |
| ProFunds | 0.00% | 8,394 | 7,722 | 1149.11% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 67,754 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 45,654 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 42,300 | 15,900 | 60.23% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 58,294 | -2,261 | -3.73% | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 1,646 | - | - | Mar 28, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 31,179 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 49,522 | 14,255 | 40.42% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,331 | 2,444 | 50.01% | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 7,443 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 946,720 | - | - | Jan 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 31,402 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 1,567 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,362 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 4,232,423 | 1,050,649 | 33.02% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 307,460 | 70,830 | 29.93% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 16,081 | - | - | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 2,312 | - | - | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 230,320 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 368,117 | 52,428 | 16.61% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 712 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 12,954 | 12,954 | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,811 | 5,907 | 49.62% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 51,856 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,700 | 1,000 | 37.04% | Mar 28, 2024 |
| VALIC Co I | 0.00% | 30,674 | 604 | 2.01% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 951 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 353 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,808 | 876 | 8.82% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 19,946 | 4,802 | 31.71% | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 457 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 5,640 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 10,742 | - | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 7,300 | - | - | Mar 31, 2024 |
| 1290 Funds | 0.00% | 80,111 | 23,267 | 40.93% | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 17,200 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 16,177 | 14,768 | 1048.12% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 128,116 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 10,060 | 1,772 | 21.38% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 37,396 | 11,194 | 42.72% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 47 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 41,830 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 92,900 | 27,500 | 42.05% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,160 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 109,655 | - | - | Mar 28, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,651 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 11,110 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 9,056 | 179 | 2.02% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,419 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 48,503 | 16,903 | 53.49% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 4,552 | - | - | Feb 29, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 4,100 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 393 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 1,787 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 57,549 | 22,798 | 65.60% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 51,043 | 46,028 | 917.81% | Jan 31, 2024 |
Ocular Therapeutix's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 14.52K shares, compromising 4.07% of its total assets.
Ocular Therapeutix Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 142 | -6.58% |
| 31 Mar, 24 | 152 | 24.59% |
| 31 Dec, 23 | 122 | 3.39% |
| 30 Sep, 23 | 118 | -16.90% |
| 30 Jun, 23 | 142 | 7.58% |
| 31 Mar, 23 | 132 | 9.09% |
| 31 Dec, 22 | 121 | -10.37% |
| 30 Sep, 22 | 135 | 8.00% |
| 30 Jun, 22 | 125 | -6.02% |
| 31 Mar, 22 | 133 | -10.74% |
| 31 Dec, 21 | 149 | 0.68% |
| 30 Sep, 21 | 148 | -5.13% |
| 30 Jun, 21 | 156 | -1.27% |
| 31 Mar, 21 | 158 | 0.64% |
| 31 Dec, 20 | 157 | 41.44% |
| 30 Sep, 20 | 111 | -0.89% |
| 30 Jun, 20 | 112 | 14.29% |
| 31 Mar, 20 | 98 | 18.07% |
| 31 Dec, 19 | 83 | -1.19% |
| 30 Sep, 19 | 84 | 10.53% |
| 30 Jun, 19 | 76 | 4.11% |
| 31 Mar, 19 | 73 | - |
| 31 Dec, 18 | 73 | -7.59% |
| 30 Sep, 18 | 79 | 8.22% |
| 30 Jun, 18 | 73 | 4.29% |
| 31 Mar, 18 | 70 | -6.67% |
| 31 Dec, 17 | 75 | -7.41% |
| 30 Sep, 17 | 81 | -3.57% |
| 30 Jun, 17 | 84 | 2.44% |
| 31 Mar, 17 | 82 | - |
| 31 Dec, 16 | 82 | 3.80% |
| 30 Sep, 16 | 79 | 1.28% |
| 30 Jun, 16 | 78 | 18.18% |
| 31 Mar, 16 | 66 | -9.59% |
| 31 Dec, 15 | 73 | 1.39% |
| 30 Sep, 15 | 72 | -1.37% |
| 30 Jun, 15 | 73 | 28.07% |
| 31 Mar, 15 | 57 | 54.05% |
| 31 Dec, 14 | 37 | 8.82% |
| 30 Sep, 14 | 34 | - |
As of 30 Jun 24, 142 institutions are holding Ocular Therapeutix's shares, representing a decrease of -6.58% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 135,831,993 | 9.61% |
| 31 Mar, 24 | 123,928,594 | 68.68% |
| 31 Dec, 23 | 73,470,456 | 82.44% |
| 30 Sep, 23 | 40,270,842 | -7.02% |
| 30 Jun, 23 | 43,311,493 | 7.38% |
| 31 Mar, 23 | 40,335,372 | 1.40% |
| 31 Dec, 22 | 39,779,547 | -6.75% |
| 30 Sep, 22 | 42,661,201 | -3.46% |
| 30 Jun, 22 | 44,189,749 | 1.12% |
| 31 Mar, 22 | 43,698,196 | 5.47% |
| 31 Dec, 21 | 41,433,437 | -6.67% |
| 30 Sep, 21 | 44,393,997 | -8.01% |
| 30 Jun, 21 | 48,260,941 | 2.37% |
| 31 Mar, 21 | 47,143,865 | -6.43% |
| 31 Dec, 20 | 50,384,689 | 26.67% |
| 30 Sep, 20 | 39,775,810 | 2.84% |
| 30 Jun, 20 | 38,678,954 | 35.81% |
| 31 Mar, 20 | 28,479,995 | 12.97% |
| 31 Dec, 19 | 25,209,460 | 9.18% |
| 30 Sep, 19 | 23,089,120 | 1.69% |
| 30 Jun, 19 | 22,704,361 | 1.71% |
| 31 Mar, 19 | 22,322,490 | 3.20% |
| 31 Dec, 18 | 21,630,827 | -0.08% |
| 30 Sep, 18 | 21,648,944 | -0.81% |
| 30 Jun, 18 | 21,826,202 | 6.81% |
| 31 Mar, 18 | 20,434,886 | 51.29% |
| 31 Dec, 17 | 13,506,669 | -13.32% |
| 30 Sep, 17 | 15,581,735 | 0.50% |
| 30 Jun, 17 | 15,504,582 | -15.49% |
| 31 Mar, 17 | 18,346,523 | 5.47% |
| 31 Dec, 16 | 17,394,280 | -7.41% |
| 30 Sep, 16 | 18,785,718 | -3.53% |
| 30 Jun, 16 | 19,472,452 | -6.65% |
| 31 Mar, 16 | 20,860,674 | -6.42% |
| 31 Dec, 15 | 22,290,769 | 1.27% |
| 30 Sep, 15 | 22,012,263 | 21.81% |
| 30 Jun, 15 | 18,071,687 | 36.17% |
| 31 Mar, 15 | 13,271,637 | 74.80% |
| 31 Dec, 14 | 7,592,355 | 5.22% |
| 30 Sep, 14 | 7,215,491 | - |
Ocular Therapeutix (OCUL) has 135.83M shares outstanding as of 30 Jun 24, up 9.61% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 102.89% | 1.17% |
| 31 Mar, 24 | 93.87% | 1.24% |
| 31 Dec, 23 | 87.02% | 3.38% |
| 30 Sep, 23 | 50.74% | 1.65% |
| 30 Jun, 23 | 55.49% | 2.04% |
| 31 Mar, 23 | 52.12% | 1.95% |
| 31 Dec, 22 | 51.65% | 1.68% |
| 30 Sep, 22 | 55.42% | 1.93% |
| 30 Jun, 22 | 53.54% | 1.91% |
| 31 Mar, 22 | 52.96% | 1.80% |
| 31 Dec, 21 | 54.24% | 1.61% |
| 30 Sep, 21 | 57.99% | 1.45% |
| 30 Jun, 21 | 63.23% | 1.65% |
| 31 Mar, 21 | 61.97% | 0.90% |
| 31 Dec, 20 | 82.93% | 2.08% |
| 30 Sep, 20 | 63.14% | 1.38% |
| 30 Jun, 20 | 67.69% | 2.25% |
| 31 Mar, 20 | 54.87% | 1.77% |
| 31 Dec, 19 | 55.68% | 2.30% |
| 30 Sep, 19 | 49.18% | 1.76% |
| 30 Jun, 19 | 52.91% | 1.90% |
| 31 Mar, 19 | 52.83% | 1.91% |
| 31 Dec, 18 | 52.64% | 1.71% |
| 30 Sep, 18 | 55.48% | 1.64% |
| 30 Jun, 18 | 58.17% | 1.65% |
| 31 Mar, 18 | 59.38% | 2.86% |
| 31 Dec, 17 | 45.54% | 1.59% |
| 30 Sep, 17 | 53.57% | 1.88% |
| 30 Jun, 17 | 53.42% | 1.21% |
| 31 Mar, 17 | 66.37% | 1.36% |
| 31 Dec, 16 | 69.89% | 1.22% |
| 30 Sep, 16 | 75.58% | 1.22% |
| 30 Jun, 16 | 78.61% | 1.11% |
| 31 Mar, 16 | 84.28% | 1.04% |
| 31 Dec, 15 | 90.13% | 1.14% |
| 30 Sep, 15 | 89.07% | 1.34% |
| 30 Jun, 15 | 81.52% | 2.11% |
| 31 Mar, 15 | 62.13% | 4.88% |
| 31 Dec, 14 | 35.66% | 1.58% |
| 30 Sep, 14 | 47.58% | - |
As of 30 Jun 24, Ocular Therapeutix is held by 102.89% institutional shareholders, representing a 1.17% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 87 | -18.69% |
| 31 Mar, 24 | 107 | 69.84% |
| 31 Dec, 23 | 63 | 16.67% |
| 30 Sep, 23 | 54 | -22.86% |
| 30 Jun, 23 | 70 | 2.94% |
| 31 Mar, 23 | 68 | 25.93% |
| 31 Dec, 22 | 54 | -15.63% |
| 30 Sep, 22 | 64 | 18.52% |
| 30 Jun, 22 | 54 | -10.00% |
| 31 Mar, 22 | 60 | -22.08% |
| 31 Dec, 21 | 77 | 24.19% |
| 30 Sep, 21 | 62 | -26.19% |
| 30 Jun, 21 | 84 | 10.53% |
| 31 Mar, 21 | 76 | -24.75% |
| 31 Dec, 20 | 101 | 83.64% |
| 30 Sep, 20 | 55 | -29.49% |
| 30 Jun, 20 | 78 | 50.00% |
| 31 Mar, 20 | 52 | 26.83% |
| 31 Dec, 19 | 41 | 5.13% |
| 30 Sep, 19 | 39 | 2.63% |
| 30 Jun, 19 | 38 | 11.76% |
| 31 Mar, 19 | 34 | 3.03% |
| 31 Dec, 18 | 33 | -10.81% |
| 30 Sep, 18 | 37 | - |
| 30 Jun, 18 | 37 | 8.82% |
| 31 Mar, 18 | 34 | 25.93% |
| 31 Dec, 17 | 27 | -15.63% |
| 30 Sep, 17 | 32 | -15.79% |
| 30 Jun, 17 | 38 | -13.64% |
| 31 Mar, 17 | 44 | 2.33% |
| 31 Dec, 16 | 43 | 2.38% |
| 30 Sep, 16 | 42 | -22.22% |
| 30 Jun, 16 | 54 | 74.19% |
| 31 Mar, 16 | 31 | -20.51% |
| 31 Dec, 15 | 39 | -25.00% |
| 30 Sep, 15 | 52 | -18.75% |
| 30 Jun, 15 | 64 | 48.84% |
| 31 Mar, 15 | 43 | 65.38% |
| 31 Dec, 14 | 26 | -23.53% |
| 30 Sep, 14 | 34 | - |
87 institutional shareholders have increased their position in OCUL stock as of 30 Jun 24 compared to 107 in the previous quarter (a -18.69% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 25 | 8.70% |
| 31 Mar, 24 | 23 | -23.33% |
| 31 Dec, 23 | 30 | 3.45% |
| 30 Sep, 23 | 29 | -23.68% |
| 30 Jun, 23 | 38 | 18.75% |
| 31 Mar, 23 | 32 | -20.00% |
| 31 Dec, 22 | 40 | 8.11% |
| 30 Sep, 22 | 37 | - |
| 30 Jun, 22 | 37 | -11.90% |
| 31 Mar, 22 | 42 | -2.33% |
| 31 Dec, 21 | 43 | -14.00% |
| 30 Sep, 21 | 50 | 51.52% |
| 30 Jun, 21 | 33 | -28.26% |
| 31 Mar, 21 | 46 | 27.78% |
| 31 Dec, 20 | 36 | 16.13% |
| 30 Sep, 20 | 31 | 210.00% |
| 30 Jun, 20 | 10 | -54.55% |
| 31 Mar, 20 | 22 | 15.79% |
| 31 Dec, 19 | 19 | 46.15% |
| 30 Sep, 19 | 13 | -13.33% |
| 30 Jun, 19 | 15 | -21.05% |
| 31 Mar, 19 | 19 | - |
| 31 Dec, 18 | 19 | 26.67% |
| 30 Sep, 18 | 15 | 7.14% |
| 30 Jun, 18 | 14 | 40.00% |
| 31 Mar, 18 | 10 | -60.00% |
| 31 Dec, 17 | 25 | 19.05% |
| 30 Sep, 17 | 21 | -12.50% |
| 30 Jun, 17 | 24 | 33.33% |
| 31 Mar, 17 | 18 | -30.77% |
| 31 Dec, 16 | 26 | 100.00% |
| 30 Sep, 16 | 13 | 18.18% |
| 30 Jun, 16 | 11 | -8.33% |
| 31 Mar, 16 | 12 | -42.86% |
| 31 Dec, 15 | 21 | 200.00% |
| 30 Sep, 15 | 7 | 16.67% |
| 30 Jun, 15 | 6 | -40.00% |
| 31 Mar, 15 | 10 | 25.00% |
| 31 Dec, 14 | 8 | - |
| 30 Sep, 14 | - | - |
25 institutional shareholders have reduced their position in OCUL stock as of 30 Jun 24 compared to 23 in the previous quarter (a 8.70% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 142 | -6.58% | 135,831,993 | 9.61% | 102.89% | 1.17% | 87 | -18.69% | 25 | 8.70% |
| 31 Mar, 24 | 152 | 24.59% | 123,928,594 | 68.68% | 93.87% | 1.24% | 107 | 69.84% | 23 | -23.33% |
| 31 Dec, 23 | 122 | 3.39% | 73,470,456 | 82.44% | 87.02% | 3.38% | 63 | 16.67% | 30 | 3.45% |
| 30 Sep, 23 | 118 | -16.90% | 40,270,842 | -7.02% | 50.74% | 1.65% | 54 | -22.86% | 29 | -23.68% |
| 30 Jun, 23 | 142 | 7.58% | 43,311,493 | 7.38% | 55.49% | 2.04% | 70 | 2.94% | 38 | 18.75% |
| 31 Mar, 23 | 132 | 9.09% | 40,335,372 | 1.40% | 52.12% | 1.95% | 68 | 25.93% | 32 | -20.00% |
| 31 Dec, 22 | 121 | -10.37% | 39,779,547 | -6.75% | 51.65% | 1.68% | 54 | -15.63% | 40 | 8.11% |
| 30 Sep, 22 | 135 | 8.00% | 42,661,201 | -3.46% | 55.42% | 1.93% | 64 | 18.52% | 37 | - |
| 30 Jun, 22 | 125 | -6.02% | 44,189,749 | 1.12% | 53.54% | 1.91% | 54 | -10.00% | 37 | -11.90% |
| 31 Mar, 22 | 133 | -10.74% | 43,698,196 | 5.47% | 52.96% | 1.80% | 60 | -22.08% | 42 | -2.33% |
| 31 Dec, 21 | 149 | 0.68% | 41,433,437 | -6.67% | 54.24% | 1.61% | 77 | 24.19% | 43 | -14.00% |
| 30 Sep, 21 | 148 | -5.13% | 44,393,997 | -8.01% | 57.99% | 1.45% | 62 | -26.19% | 50 | 51.52% |
| 30 Jun, 21 | 156 | -1.27% | 48,260,941 | 2.37% | 63.23% | 1.65% | 84 | 10.53% | 33 | -28.26% |
| 31 Mar, 21 | 158 | 0.64% | 47,143,865 | -6.43% | 61.97% | 0.90% | 76 | -24.75% | 46 | 27.78% |
| 31 Dec, 20 | 157 | 41.44% | 50,384,689 | 26.67% | 82.93% | 2.08% | 101 | 83.64% | 36 | 16.13% |
| 30 Sep, 20 | 111 | -0.89% | 39,775,810 | 2.84% | 63.14% | 1.38% | 55 | -29.49% | 31 | 210.00% |
| 30 Jun, 20 | 112 | 14.29% | 38,678,954 | 35.81% | 67.69% | 2.25% | 78 | 50.00% | 10 | -54.55% |
| 31 Mar, 20 | 98 | 18.07% | 28,479,995 | 12.97% | 54.87% | 1.77% | 52 | 26.83% | 22 | 15.79% |
| 31 Dec, 19 | 83 | -1.19% | 25,209,460 | 9.18% | 55.68% | 2.30% | 41 | 5.13% | 19 | 46.15% |
| 30 Sep, 19 | 84 | 10.53% | 23,089,120 | 1.69% | 49.18% | 1.76% | 39 | 2.63% | 13 | -13.33% |
| 30 Jun, 19 | 76 | 4.11% | 22,704,361 | 1.71% | 52.91% | 1.90% | 38 | 11.76% | 15 | -21.05% |
| 31 Mar, 19 | 73 | - | 22,322,490 | 3.20% | 52.83% | 1.91% | 34 | 3.03% | 19 | - |
| 31 Dec, 18 | 73 | -7.59% | 21,630,827 | -0.08% | 52.64% | 1.71% | 33 | -10.81% | 19 | 26.67% |
| 30 Sep, 18 | 79 | 8.22% | 21,648,944 | -0.81% | 55.48% | 1.64% | 37 | - | 15 | 7.14% |
| 30 Jun, 18 | 73 | 4.29% | 21,826,202 | 6.81% | 58.17% | 1.65% | 37 | 8.82% | 14 | 40.00% |
| 31 Mar, 18 | 70 | -6.67% | 20,434,886 | 51.29% | 59.38% | 2.86% | 34 | 25.93% | 10 | -60.00% |
| 31 Dec, 17 | 75 | -7.41% | 13,506,669 | -13.32% | 45.54% | 1.59% | 27 | -15.63% | 25 | 19.05% |
| 30 Sep, 17 | 81 | -3.57% | 15,581,735 | 0.50% | 53.57% | 1.88% | 32 | -15.79% | 21 | -12.50% |
| 30 Jun, 17 | 84 | 2.44% | 15,504,582 | -15.49% | 53.42% | 1.21% | 38 | -13.64% | 24 | 33.33% |
| 31 Mar, 17 | 82 | - | 18,346,523 | 5.47% | 66.37% | 1.36% | 44 | 2.33% | 18 | -30.77% |
| 31 Dec, 16 | 82 | 3.80% | 17,394,280 | -7.41% | 69.89% | 1.22% | 43 | 2.38% | 26 | 100.00% |
| 30 Sep, 16 | 79 | 1.28% | 18,785,718 | -3.53% | 75.58% | 1.22% | 42 | -22.22% | 13 | 18.18% |
| 30 Jun, 16 | 78 | 18.18% | 19,472,452 | -6.65% | 78.61% | 1.11% | 54 | 74.19% | 11 | -8.33% |
| 31 Mar, 16 | 66 | -9.59% | 20,860,674 | -6.42% | 84.28% | 1.04% | 31 | -20.51% | 12 | -42.86% |
| 31 Dec, 15 | 73 | 1.39% | 22,290,769 | 1.27% | 90.13% | 1.14% | 39 | -25.00% | 21 | 200.00% |
| 30 Sep, 15 | 72 | -1.37% | 22,012,263 | 21.81% | 89.07% | 1.34% | 52 | -18.75% | 7 | 16.67% |
| 30 Jun, 15 | 73 | 28.07% | 18,071,687 | 36.17% | 81.52% | 2.11% | 64 | 48.84% | 6 | -40.00% |
| 31 Mar, 15 | 57 | 54.05% | 13,271,637 | 74.80% | 62.13% | 4.88% | 43 | 65.38% | 10 | 25.00% |
| 31 Dec, 14 | 37 | 8.82% | 7,592,355 | 5.22% | 35.66% | 1.58% | 26 | -23.53% | 8 | - |
| 30 Sep, 14 | 34 | - | 7,215,491 | - | 47.58% | - | 34 | - | - | - |
Ocular Therapeutix Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Ocular Therapeutix's stock was made by LINDSTROM RICHARD L MD on Jul 26 2024, selling 11,363 shares at $8.80 per share (valued at $99.99K).
Ocular Therapeutix Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 12 | - | - |
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 22 | 7 | 314.29% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 4 | 1 | 400.00% |
| Q2 2023 | 12 | - | - |
| Q1 2023 | 11 | 5 | 220.00% |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 4 | 3 | 133.33% |
| Q2 2022 | 17 | 1 | 1700.00% |
| Q1 2022 | 20 | - | - |
| Q4 2021 | 7 | 3 | 233.33% |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 6 | 1 | 600.00% |
| Q1 2021 | 7 | 1 | 700.00% |
| Q4 2020 | 6 | 6 | 100.00% |
| Q3 2020 | - | - | - |
| Q2 2020 | 7 | - | - |
| Q1 2020 | 13 | - | - |
| Q4 2019 | 2 | 1 | 200.00% |
12 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ocular Therapeutix's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | 1 | 10 | 10.00% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 5 | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 1 | - | - |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 6 | - | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | 1 | 100.00% |
| Q3 2020 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | 9 | - | - |
| Q4 2019 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Ocular Therapeutix's stocks.
Ocular Therapeutix Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| ACHL | Achilles Therapeutics plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
OCUL Ownership FAQ
Who Owns Ocular Therapeutix?
Ocular Therapeutix is owned by institutional shareholders (102.89%), insiders (0.92%), and public (-3.80%). The largest institutional shareholder of Ocular Therapeutix is SUMMER ROAD LLC (11.28% of total shares) and the top mutual fund owner is SPARROW FUNDS (4.07% of total shares).
Who are the major institutional shareholders of Ocular Therapeutix?
Ocular Therapeutix's major institutional shareholders are SUMMER ROAD LLC, VR ADVISER, LLC, DEEP TRACK CAPITAL, LP, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 45.83% of the company's share outstanding.
How many Ocular Therapeutix shareholders are there?
As of Jun 2024, there are 142 institutional shareholders of Ocular Therapeutix.
What percentage of Ocular Therapeutix is owned by SUMMER ROAD LLC?
SUMMER ROAD LLC owns 14.89M shares of Ocular Therapeutix, representing 11.28% of the company's total shares outstanding, valued at $101.82M (as of Jun 2024).
What percentage of Ocular Therapeutix is owned by VR ADVISER, LLC?
As of Jun 2024, VR ADVISER, LLC holds 12.76M shares of Ocular Therapeutix (OCUL), compromising 9.67% of the company, valued at $87.3M.
What percentage of Ocular Therapeutix is owned by DEEP TRACK CAPITAL, LP?
DEEP TRACK CAPITAL, LP is the third largest holder of Ocular Therapeutix. The company owns 12.72M of the company's shares outstanding (worth $87.01M).